Indication for Use: Noctura 400 is a Class IIa medical device that is CE and UKCA certified. It is a safe, non-invasive treatment for Diabetic Retinopathy and Diabetic Macular Oedema.
Contraindications for Use
Use Noctura 400 only for the condition(s) stated in the indication for use. Noctura 400 has not been tested for any other conditions.
If you have been diagnosed with Glaucoma, please consult your clinical prescriber before using Noctura 400.
Noctura 400 is not recommended to be used with the following types of Glaucoma: Acute Angle-closure Glaucoma and Neovascular Glaucoma. The safe use of Noctura 400 with Acute Angle-closure Glaucoma and Neovascular Glaucoma has not been tested and the risk is unknown.
If you have severe sight restricting Cataracts or Corneal Opacity you should consult your clinical prescriber before using Noctura 400. These conditions may prevent sufficient light from reaching the retina and could reduce the effectiveness of treatment. Following cataract surgery and recovery, use of Noctura 400 can commence.
Noctura 400 should not be used if you have Symptomatic Diabetic Keratopathy. Its safe use with this condition has not been tested and the risk is unknown.
If you are pregnant, or planning to become pregnant, please consult your clinical prescriber before using Noctura 400. Its safety during pregnancy has not been tested.
Do not use Noctura 400 while you have an eye infection or discharge from the eyes. Please seek appropriate medical advice before resuming use.
Do not use Noctura 400 if you have a known sensitivity to light or are taking medication that may increase your sensitivity to light.
